Literature DB >> 11755789

Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission.

Frédéric A Meunier1, Giampietro Schiavo, Jordi Molgó.   

Abstract

The neuromuscular junction is one of the most accessible mammalian synapses which offers a useful model to study long-term synaptic modifications occurring throughout life. It is also the natural target of botulinum neurotoxins (BoNTs) causing a selective blockade of the regulated exocytosis of acetylcholine thereby triggering a profound albeit transitory muscular paralysis. The scope of this review is to describe the principal steps implicated in botulinum toxin intoxication from the early events leading to a paralysis to the cellular response implementing an impressive synaptic remodelling culminating in the functional recovery of neuromuscular transmission. BoNT/A treatment promotes extensive sprouting emanating from intoxicated motor nerve terminals and the distal portion of motor axons. The current view is that sprouts have the ability to form functional synapses as they display a number of key proteins required for exocytosis: SNAP-25, VAMP/synaptobrevin, syntaxin-I, synaptotagmin-II, synaptophysin, and voltage-activated Na+, Ca2+ and Ca2+-activated K+ channels. Exo-endocytosis was demonstrated (using the styryl dye FM1-43) to occur only in the sprouts in vivo, at the time of functional recovery emphasising the direct role of nerve terminal outgrowth in implementing the restoration of functional neurotransmitter release (at a time when nerve stimulation again elicited muscle contraction). Interestingly, sprouts are only transitory since a second distinct phase of the rehabilitation process occurs with a return of synaptic activity to the original nerve terminals. This is accompanied by the elimination of the dispensable sprouts. The growth or elimination of these nerve processes appears to be strongly correlated with the level of synaptic activity at the parent terminal. The BoNT/A-induced extension and later removal of "functional" sprouts indicate their fundamental importance in the rehabilitation of paralysed endplates, a finding with ramifications for the vital process of nerve regeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755789     DOI: 10.1016/s0928-4257(01)00086-9

Source DB:  PubMed          Journal:  J Physiol Paris        ISSN: 0928-4257


  55 in total

1.  Functional end-plate recovery in long-term botulinum toxin therapy of hemifacial spasm: a nerve conduction study.

Authors:  C Butera; R Guerriero; S Amadio; D Ungaro; H Tesfaghebriel; F Bianchi; G Comi; U Del Carro
Journal:  Neurol Sci       Date:  2012-02-25       Impact factor: 3.307

2.  Wound botulism in drug users: a still underestimated diagnosis.

Authors:  C Rodolico; E Barca; L Fenicia; F Anniballi; A U Sinardi; P Girlanda
Journal:  Neurol Sci       Date:  2010-06-15       Impact factor: 3.307

3.  The role of exoproteases in governing intraneuronal metabolism of botulinum toxin.

Authors:  Lance L Simpson; Andrew B Maksymowych; Hirokazu Kouguchi; Garrett Dubois; Roop S Bora; Suresh Joshi
Journal:  Protein J       Date:  2005-04       Impact factor: 2.371

4.  Abrogating Munc18-1-SNARE complex interaction has limited impact on exocytosis in PC12 cells.

Authors:  Nancy T Malintan; Tam H Nguyen; Liping Han; Catherine F Latham; Shona L Osborne; Peter J Wen; Siew Joo Tiffany Lim; Shuzo Sugita; Brett M Collins; Frederic A Meunier
Journal:  J Biol Chem       Date:  2009-05-29       Impact factor: 5.157

Review 5.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

6.  Characterizing the Bladder's Response to Onabotulinum Toxin Type A Using a Rat Model.

Authors:  Alexis A Dieter; Jennifer M Wu; Nazema Y Siddiqui; Danielle J Degoski; Jillene M Brooks; Paul C Dolber; Matthew O Fraser
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Nov/Dec       Impact factor: 2.091

7.  Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats.

Authors:  Zdravko Lacković; Veseljka Rebić; Peter F Riederer
Journal:  J Neural Transm (Vienna)       Date:  2009-08-20       Impact factor: 3.575

Review 8.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

9.  The Use of Botulinum Toxins for Chronic Pain and Headaches.

Authors:  Charles E. Argoff
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

10.  Type C botulinum toxin causes degeneration of motoneurons in vivo.

Authors:  Li-Chun Zhao; Bo Yang; Rengang Wang; Stuart A Lipton; Dongxian Zhang
Journal:  Neuroreport       Date:  2010-01-06       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.